Cargando…
Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook
Hepatocellular carcinoma (HCC) has emerged the culprit of cancer-related mortality worldwide with its dismal prognosis climbing. In recent years, ground-breaking progress has been made in systemic therapy for HCC. Targeted therapy based on specific signaling molecules, including sorafenib, lenvatini...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977221/ https://www.ncbi.nlm.nih.gov/pubmed/35388357 http://dx.doi.org/10.2147/JHC.S358082 |